Catumaxomab (Removab)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Catumaxomab (Removab), covering 2012-10-03 to 2012-10-03. Get the full timeline:
Most recent: Clinical Trial Update: Phase II Study of the Trifunctional Antibody Catumaxomab Administered Intra- and Postoperatively in Patients With Ovarian Cancer [Phase 2]